Impact on efficacy of target reduction of two FDA-approved ASO drugs by intracellular glucose levels in in vitro cell models
2025 · Molecular Therapy — Nucleic Acids · 3 citations
https://doi.org/10.1016/j.omtn.2025.102487
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
402
Citations
7
h-index
7
i10-index
Sherouk M. Tawfik is an academic researcher. The author has contributed to research in topics: Pancreatic function and diabetes & RNA Interference and Gene Delivery & Meat and Animal Product Quality. The author has an h-index of 7, co-authored 17 publications.
Click to start Chat